# OnCo record precigen (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/precigen/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "precigen" ;
  schema:name "Precigen"@en ;
  schema:alternateName "Intrexon"@en ;
  schema:description "Precigen is a US-based biotechnology company that leads 2 cancer trials in OnCo, testing the adenoviral immunotherapies PRGN-2012 (Papzimeos) and PRGN-2009 in rare cancers of childhood and cervical cancer."@en ;
  schema:url <https://onco.cc/companies/precigen/>, <https://precigen.com> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://precigen.com>, <https://clinicaltrials.gov/search?lead=Precigen%2C%20Inc> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/rare-childhood-cancers/>, <https://onco.cc/cancers/cervical/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:trials <https://onco.cc/trials/nct04724980/>, <https://onco.cc/trials/nct06157151/> .
